A Letter from Bula: Coronavirus (COVID-19) Update

Good afternoon,

Thank you all for the fantastic feedback we’ve received following our updates. The Bula team worked over the weekend to publish the following sub-regulations, and you’ll find them listed below and in the Current Law Database.

Many states are publishing updates to EOs, guidance and regulations. We are working to improve searchability to ensure you’re looking at the most recent version – with previous versions listed as well. 

Some trends since Friday:

Bula’s weekend updates:

  • NC Subreg 03-22-2020 BoP Announcement: Prescriptions for Hydroxychloroquine, Chlorqouine, Azithromycin, Kaletera, and Other Medications
  • OH Subreg 03-22-2020 BoP Order: Prescription requirements for chloroquine or hydroxychloroquine
  • PA Subreg 03-22-2020 : Pennsylvania Suspends Certain Licensing and Regulatory Requirements for Pharmacies and Pharmacists During Coronavirus Emergency
  • AL Subreg 03-21-2020 Joint Notice of the Alabama BoMEx and BoP: Enforcement Discretion
  • AR Subreg 03-21-2020 Dept of Health letter: Chloroquine and Hydroxychloroquine Information
  • OK ADC 03-21-2020 Third Amended 2020-07 Executive Order: State of Emergency – See Sections 6, 7, 11, 15 & 16 for pharmacy info
  • MA Subreg 03-20-2020 Pharmacy FAQs COVID-19: Coronavirus Disease 2019 (COVID-19)
  • NV Subreg 03-20-2020 Board of Pharmacy Guidance: COVID-19 Information
  • OH Subreg 03-20-2020 BoP Guidance Document: COVID-19 Response Efforts
  • Fd Subreg 03-20-2020 DEA Webpage: COVID-19 Information Page
  • NM Subreg 03-20-2020 State Medicaid Program / DOI Press Release: New requirements to promote telemedicine during COVID-19 emergency
  • NM Subreg 03-20-2020 Regulation & Licensing Dept. Press Release: Boards and Commissions Division Suspending Requirement for Continuing Education During COVID-19 Public Health Emergency
  • AL Subreg 03-20-2020 Medicaid Alert: Alabama Medicaid Modifies Recipient Signature Requirement during COVID-19 Emergency
  • NV Subreg 03-20-2020 Guidance Document: Patient Counseling and Prescription Delivery in Response to COVID-19\
  • ID Subreg 03-20-2020 Memo to All Licensees and Registrants: FAQ for COVID-19 Declaration of Emergency
  • NV Subreg 03-20-2020 Guidance: Dispensing of Prescriptions for Chloroquine and Hydroxychloroquine in Response to COVID-19
  • GA ADC 03-20-2020 Executive Order: Reducing Regulations to Assist The State’s Response to the Spread of COVID-19
  • TX Subreg 03-20-2020 Governor’s Press Release: Waiver of Regulations to Support Pharmacy Operations, Allow Telephonic Consultations\
  • TX ADC E 22-291.30: Medication Limitations (Emergency Rule)
  • TX Subreg 2020-03-20 Tx BoP Website: Resources for Pharmacy Professionals Rule Waivers & Emergency Procedure Regulations
  • Fd Subreg 03-20-2020 DEA Policy: Registrant Guidance on Controlled Substance Prescription Refills
  • KY Subreg 03-20-2020 BoP Guidelines: Modifications to KRS 315 and 201 KAR Ch. 2 to allow remote pharmacy
  • Fd Subreg 03-20-2020 CMS Letter to Part D Plan Sponsors: Minimizing Face-to-Face Contact for Medication Delivery or Dispensing
  • MS Subreg 03-20-2020 BoP Clarification: Clarification of Prescription Signature Requirements
  • TX Subreg 03-20-2020 BoP Guidance: Emergency Dispensing of Prescription Medications
  • Fd Subreg 03-13-2020 FDA Guidance: Policy for Temporary Compounding of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency Immediately in Effect Guidance for Industry
  • OK ADC 03-19-2020 Second Amended Executive Order No. 2020-07 (Expires 4-18-2020): COVID-19
  • OH Subreg 03-19-2020 BoP Guidance Document: COVID-19 Response Efforts
  • MO Subreg 03-19-2020 Board of Pharmacy Guidance Document: COVID-19 INFORMATION
  • MN Subreg 03-19-2020 (updated): Frequently Asked Questions: COVID-19
  • MD Subreg 03-19-2020 Board of Pharamcy Memo : COVID-19 Guidance Information
  • TX Subreg 03-09-2020 BoP Notification: Emergency Dispensing of Prescription Medications and COVID-19
  • WA Subreg 03-19-2020 — Plan-19: Pharmacy Quality Assurance Commission’s 2019 Novel Coronavirus (COVID-19) Response Packet ‘A Live Plan’
  • NC Subreg 03-19-2020 NC Board of Pharmacy Order: Temporary Reactivation of Pharmacist Licenses to Provide Patient Care During the COVID-19 State of Emergency
  • IL ADC 03-19-2020 Executive Order 2020-09: Executive Order to Expand Telehealth Services and Protect Health Care Providers in Response to COVID-19
  • OR Subreg 03-19-2020 BoP Comprehensive Communication: COVID-19 UPDATE- Oregon Board of Pharmacy (OBOP) Information, March 19, 2020
  • TN ADC 03-19-2020 Executive Order 15: An Order Suspending Provisions of Certain Statutes and Rules and Taking Other Necessary Measures in Order to Facilitate the Treatment and Containment of COVID-19
  • Fd Subreg 03-19-2020 CMS Letter: Coverage and Payment Related to COVID-19 Medicare (Requests for Part B Refills; Part D Coverage; Vaccines; etc)
  • OR ADC 03-19-2020 Executive Order 20-10 : Conserving Personal Protective Equipment and Hospital Beds, Protecting Health Care Workers, Postponing Non Urgent Health Care Procedures, and Restricting Visitation in Response to COVID
  • TX Subreg 03-19-2020 Medical Board Press Release: TMB Waiver for Chronic Pain Patients Granted by Governor Abbott
  • ID Subreg 03-19-2020 Idaho BoP Memorandum: Temporary Rule 704 Medication Limitations
  • OH Subreg 03-19-2020 BoP Guidance Document: Implementing Infection Control Procedures
  • OH Subreg 03-09-2020 BoP Guidance Document: Implementing Infection Control Procedures
  • ME Subreg 03-19-2020 Maine Dept of HHS Guidance: Compounding Over the Counter Hand Sanitizer
  • AR Subreg 03-19-2020 Board of Pharmacy Recommendations : Concerning Potential Compounding Garb Shortages
  • TX Subreg 03-19-2020 Tx BOP Letter: Emergency Dispensing of Prescription Medications
  • NC Subreg 03-19-2020 North Carolina Board of Pharmacy Recommendations: Concerning Potential Compounding Garb Shortages
  • MS Subreg 03-19-2020 BoP Resolution: CII Drugs — Emergency Declaration (expires 4/19/2020)
  • WY Subreg 03-18-2020 Board of Pharmacy Guidance Document: COVID-19

Best,
Laara

Laara van Loben Sels
Vice President, Marketing and Sales

office: 480-339-8384   mobile: 480-285-5778
Book a Meeting with Me
2150 E Highland Ave.
Phoenix, AZ
www.bulalaw.com

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.
You need to agree with the terms to proceed

Menu